The demonstration by Harris, Ray, and Ward (1) of a correlation between the urinary excretion of ascorbic acid and the dietary intake has led to many investigations of ascorbic acid metabolism based on the technique suggested by these authors. Sendroy and Schultz (2) have given especial attention to some of the possible factors affecting tests based on urinary excretion values. A urinary excretion test might also be affected by another factor, namely, that of kidney function.
The demonstration by Harris, Ray, and Ward (1) of a correlation between the urinary excretion of ascorbic acid and the dietary intake has led to many investigations of ascorbic acid metabolism based on the technique suggested by these authors. Sendroy and Schultz (2) have given especial attention to some of the possible factors affecting tests based on urinary excretion values. A urinary excretion test might also be affected by another factor, namely, that of kidney function.
The difference between the ascorbic acid in the test dose and the amount in the urinary output has been ascribed either to a deficiency, leading to storage, or to an increased destruction of the material in the body. Nevertheless, it might be increased, especially in disease, by a lowered excretion rate. In the great majority of nutrition studies, there has probably been little error involved in the neglect of this factor, or in the tacit assumption that renal function was unvarying or normal in the cases observed. However, since such tests may and, indeed, have been applied under conditions where kidney function was undoubtedly abnormal, it seemed desirable to investigate the effect of this factor and to learn something of the mode of renal excretion of ascorbic acid. Drigalski (3) , who studied a variety of pathological conditions, among which were Addison's disease, acute nephritis, and nephrosis (but one case in each condition), concluded that the excretion of ascorbic acid in the urine was independent of changes in kidney function with respect to glomerular or tubular damage. Siwe (4) studied one case of Addison's disease and found a decreased excretion of ingested ascorbic acid. Shortly thereafter, Wilkinson, Manch, and Ashford (5) , studied the ascorbic acid urine excretion of three women with Addison's disease, and observed a poor response to test doses. 1 Present address-Department of Medicine, Loyola University School of Medicine, Mercy Hospital, Chicago.
2 Present address-University of Chicago, Chicago.
They concluded that the degree of ascorbic acid subnutritioni in their cases paralleled the severity of the disease. However, they did not take into consideration the possibility that their results indicated not a disturbance of ascorbic acid metabolism but a functional renal insufficiency, which is one of the well known characteristics of Addison's disease. Van Eekelen's (6) observation that a surplus excretion of ascorbic acid occurs in the urine when the blood level of about 1.3 mgm. per 100 cc. is exceeded, seems to have been the first indication that a renal threshold was involved. Lund (7) and Faulkner and Taylor (8) have also concluded that the ascorbic acid concentration in the urine is dependent on the serum concentration. The latter authors found a threshold level of about 1.4 mgm. per 100 cc. of serum. Because of the unknown effect of renal impairment on urinary excretion, Wright, Lilienfeld, and MacLenathen (9) have advocated, as a criterion of nutritional saturation of ascorbic acid, a study of the blood curve in addition to measurement of the urinary excretion, after intravenous injection of ascorbic acid. More recently, Wright and MacLenathen (10) have studied a patient who had malignant hypertension, with a nitrogen retention definitely indicative of a diminished renal function. This individual, despite a history of adequate ascorbic acid intake, showed a distinct retention of the injected test dose. The low output in the urine, usually a sign of subnutrition, could therefore be attributed to kidney damage.
On the basis of simultaneous ascorbic acid and inulin clearances in man (in presumably normal individuals) over a wide range of plasma ascorbic acid concentrations, Friedman, McGoey, and Ralli (11) , and Ralli, Friedman, and Rubin (12) have found further evidence of the threshold nature of ascorbic acid renal excretion.
The present paper is concerned with a quantitative study of the effect of various degrees of 135 renal impairment on the urinary excretion of ascorbic acid in man. The excretion after the administration of large test doses was determined under conditions as normal as possible with respect to the nutritional and metabolic factors affecting the test. The urinary output was then directly correlated with renal function, which was subsequently determined by simultaneous ascorbic acid and urea clearance tests.
METHOD
As subjects, there were used eight patients previously hospitalized for some form of renal disease, and four normal individuals serving as controls.
Ascorbic acid utilization test
This was not done at this time on the normal subjects, two of whom (Subjects 9 and 10, Table II) had been tested previously. The utilization index for normals has been found by Sendroy and Schultz (2) to vary only within the average limits of 67.5 + 5.5. The index was determined, however, for each patient, it being ascertained that the diet had been adequate with respect to ascorbic acid, prior to the excretion test. Of these cases, none was disturbed by digestive (anorexia, etc.) or metabolic (fever, etc.) disorders during the test.
The urinary excretion test was carried out, with a few modifications, according to the technique of Sendroy and Schultz (2) . The diet during the test contained the minimum of ascorbic acid (less than 12 mgm. daily). After 48 hours, this was supplemented, for the next seven days, by the addition of 250 mgm. of "Redoxon" (1-ascorbic acid, Hoffman-La Roche) daily, taken after breakfast. Fluid intake was somewhat restricted.
Collection of urine specimens. At the beginning of a test period, the urine voided at 8 a.m. was discarded. The last specimen for every 24-hour period was obtained at 8 a.m. Although Sendroy and Schultz's method (2) of collection has been shown to give satisfactory results, the following procedure, involving the use of a preservative to prevent ascorbic acid oxidation, was adopted because of its greater convenience and accuracy.
All of the urine voided was quickly transferred to, and stored in, 750 cc. specimen bottles. Usually, two bottles sufficed for the 24-hour collection. Each c.p. Between voidings, and between the time of the last specimen collection and that of the analysis, the bottles were kept stoppered, in a refrigerator, at about 50 C.
Titration of urine specimens. For analysis, the total 24-hour output (together with the added preservative) was mixed and measured in a graduated cylinder, from which duplicate samples of from 2 to 20 cc. were withdrawn, depending on the concentration of ascorbic acid present. Water, to bring the total volume to about 48 cc., and 2.5 cc. of glacial acetic acid 4 were added. Titration with 2,6-dichlorophenol indophenol was carried out as described by Sendroy and Schultz (2), except that the indicator was standardized against a solution of ascorbic acid (" Redoxon ") in 2 per cent metaphosphoric acid instead of in water.
Urea and ascorbic acid clearance iests Simultaneous clearances were done on all subjects, patients and normals, after the completion of the urinary excretion studies. When the clearance test was begun some time after the utilization test was finished, large doses of ascorbic acid were fed during the interval, in order to avoid the complications of a possible "undersaturation."
The clearances were determined by the technique used by Van Slyke and coworkers, with modifications as described for urea by Van Slyke, Page, Hiller, and Kirk (13) . On the day of the experiment, the subject was deprived of breakfast. At 6 a.m. he received 200 cc. of water per os, followed at 7 a.m. by 500 mgm. of " Redoxon" and 200 cc. of water. At 8 a.m. an additional 200 cc. of water were given. At 9 a.m. the first of two one-hour periods was started. At the middle of each period of urine collection, blood was drawn.
Urine analyses. The urine was transferred, immediately after collection, to a measuring cylinder (containing no preservative), covered with mineral oil, and then immediately analyzed for ascorbic acid as described above. Urea analyses were done according to Van (13) .
The preservation of ascorbic acid in urine. In studying some of the factors involved in the oxidation of ascorbic acid in the average, untreated urine over varying periods of time prior to analysis, Sendroy and Schultz (2) showed that the oxygen tension was the most important. They were able to retard oxidation by exclusion of air from the sample bottles, which were stored overnight in the cold. Although their procedure gave satisfactory results, it was thought desirable to use a simpler technique, and one which would eliminate the loss of titratable ascorbic acid, in the presence of air, by inhibition of the action of oxidative catalysts such as copper (16, 17) .
Fujita and Iwatake (18) found that 2 per cent metaphosphoric acid greatly retarded spontaneous oxidation of ascorbic acid solutions, a fact confirmed by Musulin and King (19) . We endeavored to use this material as a protective agent for urinary ascorbic acid. Solid HPOs, to make a concentration of 2 or 5 per cent in solution, was added to urine samples, with and without added ascorbic acid. Portions of the urine samples were immediately titrated with 2,6-dichlorophenol indophenol. The remainder was then stored for about 24 hours in the refrigerator, in specimen bottles exposed either to onehalf volume of air or merely to the bubble left when a completely filled bottle was stoppered. Varying amounts of toluene were also used. After 24 hours, the samples were again analyzed for ascorbic acid. The results are indicated in Table I . Apparently, under these conditions, there is a loss of titratable material equivalent in concentration to from 0 to 3 mgm. of ascorbic acid per 100 cc. of urine. The percentage loss will therefore tend to be greater in the samples of lower concentrations although the variation from urine to urine is such that no rule of prediction may be applied. In general, it may be concluded from these results that in the presence of air, at low temperature (50 C.) over a period of 24 hours, ascorbic acid may be preserved in urine, in the presence of 5 per cent metaphosphoric acid and 0.2 per cent toluene, with a probable loss of 6 per cent.
While we were engaged in the preliminary studies of the effect of metaphosphoric acid, Dr. E. S. G. Barron informed us that he had already found a suitable preservative for urinary ascorbic acid, and kindly suggested its use for our studies, which we were anxious to do while the clinical material was available. The inhibitory effect of 8-hydroxyquinoline on ascorbic acid oxidation in vegetable and fruit juices has since been reported by Barron, Barron, and Klemperer (17) . The experimental data in support of the use of 8-hydroxyquinoline and sulfuric acid for urine analysis have not as yet been published from their laboratory. However, in the meanwhile, it will suffice for us to say that we have thoroughly tested the preservative; that we have found it, with toluene and storage in the cold, more effective than any other procedure in preventing the oxidation of ascorbic acid in the varying concentrations found in urine after a test dose; that the loss of titratable ascorbic acid The preservation of ascorbic acid in plasma. Follow- ing iFujita and Iwatake's observation (18) concerning its stabilizing influence in ascorbic acid solutions, it seemed logical to employ metaphosphoric acid for plasma analyses, since it is also an adequate blood deproteinizing agent, as has been shown by Hiller and Van Slyke (20) . When Farmer and Abt's revised procedure was published (15), we had already finished experiments, the results of which were in agreement with their work. In confirmation of their findings, and those of Pijoan, Townsend, and Wilson (21), we observed a loss, on standing, of substance titratable with 2,6-dichlorophenol indophenol. This loss was presumably owing to oxidation of ascorbic acid. On the assumption that such was the case, although no proof exists that it is ascorbic acid that is lost under these conditions, it seemed that the most reliable values were those obtained for samples deproteinized within the minimum time after withdrawal of blood.
In order to prevent such losses of titratable ascorbic acid, Pijoan and Klemperer (22) have recommended as an inhibitor the use of 0.1 per cent KCN in blood before deproteinization. In testing their procedure, we did find increased values as a result of adding KCN to blood, but KCN did not prevent the loss of titratable ascorbic acid which occurred when plasma stood for 2 hours before deproteinization. Furthermore, blank analyses with the protein precipitant and KCN were too high and too variable to afford confidence in the reliability of the results. More recently, others (23, 24) have questioned the efficacy of adding KCN to whole blood when ascorbic acid titrations of metaphosphoric acid filtrates are made with 2,6-dichlorophenol indophenol. The first group of workers (Friedman, et al.) found that KCN increased the amount of dye required up to physiological concentrations in plasma. Beyond that, at higher concentrations, KCN filtrates gave lower values than the "unprotected" ones. In all cases, whatever values were obtained remained constant for almost three hours.
Farmer and Abt (24) have come to the conclusion that when KCN is used with their procedure, the inhibitor invalidates results. They found that KCN does not prevent loss of ascorbic acid from blood on standing, although it does decolorize 2,6-dichlorophenol indophenol in HPO, solution and in blood plasma filtrates, thereby increasing the amount of ascorbic acid apparently present. Our own results were similar to theirs. It appears, from the foregoing, that KCN, while not preventing loss of ascorbic acid, may, under certain circumstances by its decolorizing effect on the indicator, exhibit a compensating "stabilizing" effect. At the present time, therefore, for dependable ascorbic acid values by the method of Farmer and Abt (15) , it would seem best to follow their recommendations (15, 24) that the blood be centrifuged immediately after withdrawal, the plasma separated, and deproteinizatiom carried out as quickly as possible.
RESULTS
From the results shown in Table II Table II. kidney function as judged by the maximum or standard urea clearance. With the exception of Case 6, the subjects with low percentages of normal urea clearance show a subnormal urinary excretion of ascorbic acid. The evidence is sufficient to indicate that under otherwise normal conditions of ascorbic acid intake and output, when there is impairment of renal function, as in these cases of nephritis, there is a corresponding ascorbic acid retention, and a lowered excretion in the urine.
If the ratios of ascorbic acid clearance relative to urea clearance be calculated (Column 14, (12) , that the ascorbic acid clearance increases with rising plasma concentration until a limiting value is reached.
Under the conditions of our experiments, i.e., with nephritic subjects in whom the renal lesions were in varying degrees of activity, the excretion of ascorbic acid varied with the functional capacity of the kidneys. Presumably, any disease or condition which reduces renal function, e.g., Addison's disease, would also impair the excretion of ascorbic acid. In such cases, excretion tests for ascorbic acid would give results which would be false with respect to the nutritional state. We suggest, whenever excretion tests give values indicative of ascorbic acid deficit in the body, that the tests be further controlled by adequate renal function measurements.
SUMMARY
Abnormally slow excretion of administered ascorbic acid does not necessarily indicate a low ascorbic acid content of the body when renal function is low; because renal damage retards excretion, even when no ascorbic acid deficit exists. The effect of lowered kidney function on the ascorbic acid clearance runs approximately parallel to the effect on the urea clearance.
